University of California at Davis Cancer Center

Sacramento, California 95817

1 studies enrolling now · 15 studies all time

What they study most

Acral Lentiginous Malignant Melanoma, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Rectum, Adenocarcinoma of the Stomach, Advanced Solid Tumor, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cervical Cancer, Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Endometrial Cancer, Esophageal Cancer, Extensive Stage Small Cell Lung Cancer

Studies at this site

• Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors — Recruiting now
• RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer — Running, not enrolling
• Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer — Stopped early
• Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer — Completed
• Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma — Completed
• S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer — Completed
• Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer — Completed
• Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer — Completed
• S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer — Completed
• Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma — Completed
• Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus — Stopped early
• Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma — Stopped early
• Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer — Completed
• Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors — Completed
• Bevacizumab With or Without MEDI-522 in Treating Patients With Unresectable or Metastatic Kidney Cancer — Stopped early